The University of Oklahoma and Oklahoma State University collaboration finds semaglutide treatment is associated with remarkable reductions in Alcohol Use Disorder symptoms
The first published evidence from humans that semaglutide specifically reduces the symptoms of Alcohol Use Disorder (AUD) has been published in The Journal of Clinical Psychiatry and details a recent collaboration between clinicians and scientists at the University of Oklahoma School of Community Medicine and Oklahoma State University Center for Health Sciences. The paper outlines the outcomes of six patients who received semaglutide during treatment for weight loss, demonstrating a significant and noteworthy decrease in their Alcohol Use Disorders Identification Test (AUDIT) scores.
The paper is titled "Significant ...




